Cannabis for Spasticity in Multiple Sclerosis

Stopped early · Phase 1/Phase 2

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe and effective in reducing the symptoms of spasticity and tremor in patients with secondary-progressive or primary progressive multiple sclerosis.

Key facts

Study ID
NCT00260741
Run by
Center for Medicinal Cannabis Research
People needed
60
Starts
2003-03-01
Expected to finish
2006-01-01
Last updated by the study team
2007-04-04

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.